TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Sun Pharma’s Gujarat facility under USFDA import alert

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, December 8

Advertisement

Sun Pharmaceutical Industries on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA.

Advertisement

The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022.

Import alert implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until it becomes compliant with current good manufacturing practice standards, it added.

Advertisement
Advertisement
Show comments
Advertisement